WHO Aims too Eliminate Trachoma by 2030
Table of Contents
The World Health association is targeting trachoma, the world’s leading infectious cause of blindness, for elimination by 2030 as part of its broader efforts against neglected tropical diseases.
Trachoma, a major contributor to blindness globally, is a key focus of the World Health Organization’s (WHO) campaign to eradicate neglected tropical diseases by 2030. The disease cycle begins in childhood, marked by recurring bouts of conjunctival Chlamydia trachomatis infection.
This initial infection leads to recurrent conjunctivitis, known as active trachoma. If left unaddressed,it can progress to cicatricial trachoma,characterized by scarring of the conjunctiva. This scarring can eventually cause in-turned eyelashes, a condition called trachomatous trichiasis, which typically manifests later in life.
The disease starts in childhood with repeated episodes of conjunctival Chlamydia trachomatis infection.
Frequently Asked Questions About Trachoma
- What is the SAFE strategy?
- The SAFE strategy, promoted by the WHO, encompasses Surgery for trichiasis, Antibiotics to clear infection, facial cleanliness to reduce transmission, and environmental improvement to promote hygiene.
- how is trachoma diagnosed?
- Trachoma is diagnosed through a clinical eye examination, looking for signs of active inflammation (follicles) or scarring on the inner eyelid.
- Who is most at risk of trachoma?
- Children are more susceptible to active trachoma, while adults, notably women, are more likely to experience the blinding complications of trichiasis.
